Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
5.23
+0.22 (4.39%)
Jun 6, 2025, 2:45 PM CST
SHA:603669 Revenue
Lionco Pharmaceutical Group had revenue of 50.12M CNY in the quarter ending March 31, 2025, a decrease of -34.79%. This brings the company's revenue in the last twelve months to 353.04M, up 76.18% year-over-year. In the year 2024, Lionco Pharmaceutical Group had annual revenue of 379.78M with 92.95% growth.
Revenue (ttm)
353.04M
Revenue Growth
+76.18%
P/S Ratio
10.42
Revenue / Employee
809.72K
Employees
436
Market Cap
3.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 379.78M | 182.95M | 92.95% |
Dec 31, 2023 | 196.83M | -92.43M | -31.95% |
Dec 31, 2022 | 289.26M | -451.06M | -60.93% |
Dec 31, 2021 | 740.33M | -260.67M | -26.04% |
Dec 31, 2020 | 1.00B | -634.00M | -38.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |